One of the most innovative developments related to cancer research in recent years is CAR-T cell therapy, a type of immunotherapy that modifies a patient’s own immune cells to recognize and destroy cancer cells. CAR-T therapies have already revolutionized the treatment of several blood cancers, while researchers continue to explore their potential for other tumor types.
On World Cancer Research Day, the four institutions participating in the MILenARI project (Hospital Clínic Barcelona-IDIBAPS, American University of Beirut AUB, Ospedale Pediatrico Bambino Gesù, and King Hussein Cancer Center KHCC) reaffirm their commitment to advancing cancer research through cross-border collaboration and capacity building in advanced cell therapies.
By connecting researchers, healthcare professionals, and institutions across the Mediterranean region, MILenARI facilitates knowledge transfer, promotes best practices, and contributes to more equitable access to innovative CAR-T therapies. Strengthening these collaborative networks is essential to ensure that scientific advances can be translated into tangible health benefits for cancer patients and their families.